Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)

China flag China · Delayed Price · Currency is CNY
13.32
-0.13 (-0.97%)
Apr 29, 2026, 3:04 PM CST
-11.14%
Market Cap 10.98B
Revenue (ttm) 2.68B
Net Income (ttm) 204.33M
Shares Out 824.60M
EPS (ttm) 0.25
PE Ratio 53.78
Forward PE 28.02
Dividend 0.08 (0.60%)
Ex-Dividend Date Apr 29, 2026
Volume 9,530,131
Average Volume 27,295,800
Open 13.58
Previous Close 13.45
Day's Range 13.18 - 13.58
52-Week Range 12.12 - 18.68
Beta 0.01
RSI 43.19
Earnings Date Apr 28, 2026

About SHE:002675

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti-tumor, urology, orthopedics, and anti-infection applications. It also provides active pharmaceutical ingredients, including heparin, chondroitin sulfa... [Read more]

Sector Healthcare
Founded 1998
Employees 2,583
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002675
Full Company Profile

Financial Performance

In 2025, SHE:002675's revenue was 2.74 billion, a decrease of -4.46% compared to the previous year's 2.87 billion. Earnings were 195.63 million, an increase of 6.42%.

Financial Statements

News

There is no news available yet.